Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Psychiatric Quarterly
Erschienen in: Psychiatric Quarterly 4/2011

01.12.2011 | Original Paper

The Association Between Somatic Symptoms, Anxiety Disorders and Substance Use. A Literature Review

verfasst von: Imran Hassan, Rizwan Ali

Erschienen in: Psychiatric Quarterly | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The aim of this article is to review the association between somatic symptoms, anxiety disorders and substance use. A Pub Med based literature review was conducted using various combinations of keywords related to substance use, somatic symptoms and anxiety. In various studies somatic symptoms were found to be associated with substance use. Anxiety disorders were found to have a high co-morbidity with substance use in most studies. However, several of the reviewed studies also included depressive symptoms which might have confounded the results. None of the studies was specifically aimed to find out if somatic symptoms in substance users represent an underlying primary anxiety disorder. Somatic symptoms and anxiety disorders are commonly noticed in substance users. Further studies are needed to clarify these associations since they may have significant clinical implications.
Literatur
1.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., Text Revision. Washington, American Psychiatric Association, 2000
2.
Hasin D, Katz H: [Somatoform and substance use disorders]. Psychosomatic Medicine 69:870–875, 2007
3.
Wedekind D, Engel K: Early detection of anxiety disorders. MMW Fortschritte der Medizin 149:32–35, 2007PubMed
4.
Kirmayer LJ, Young A: Culture and somatization: Clinical, epidemiological, and ethnographic perspectives. Psychosomatic Medicine 60:420–430, 1998PubMed
5.
Simon GE, VonKorff M, Piccinelli M, et al.: An international study of the relation between somatic symptoms and depression. New England Journal of Medicine 341:1329–1335, 1999PubMedCrossRef
6.
Marple RL, Kroenke K, Lucey CR, et al.: Concerns and expectations in patients presenting with physical complaints. Frequency, physician perceptions and actions, and 2-week outcome. Archives of Internal Medicine 157:1482–1488, 1997PubMedCrossRef
7.
Haug TT, Mykletun A, Dahl AA: The association between anxiety, depression, and somatic symptoms in a large population: The HUNT-II study. Psychosomatic Medicine 66:845–851, 2004PubMedCrossRef
8.
Kroenke K, Jackson JL, Chamberlin J: Depressive and anxiety disorders in patients presenting with physical complaints: Clinical predictors and outcome. American Journal of Medicine 103:339–347, 1997PubMedCrossRef
9.
P Kuo, H Yang: Substance use among adolescents in Taiwan: Associated personality traits, incompetence, and behavioral/emotional problems. Drug and Alcohol Dependence 67:27–39, 2002PubMedCrossRef
10.
Laukkanen ER, Shemeikka SL, Viinamaki HT, et al.: Heavy drinking is associated with more severe psychosocial dysfunction among girls than boys in Finland. Journal of Adolescent Health 28:270–277, 2001PubMedCrossRef
11.
Mowla A, Kianpor M, Bahtoee M, et al.: Comparison of clinical characteristics of opium-induced and independent major depressive disorder. American Journal of Drug and Alcohol Abuse 34:415–421, 2008PubMedCrossRef
12.
Tien AY, Schlaepfer TE: Self-reported somatization symptoms associated with risk for extreme alcohol use. Archives of Family Medicine 7:33–37, 1998PubMedCrossRef
13.
Kelly RH, Russo J, Katon W: Somatic complaints among pregnant women cared for in obstetrics: Normal pregnancy or depressive and anxiety symptom amplification revisited? General Hospital Psychiatry 23:107–113, 2001PubMedCrossRef
14.
Günther E: [Diagnosis and assessment of anxiety disorders]. Praxis. (Bern 1994) 87:731–734,1998
15.
Walter M, Dammann G, Wiesbeck GA, et al.: [Psychosocial stress and alcohol consumption: Interrelations, consequences and interventions]. Fortschritte der Neurologie-Psychiatrie 73:517–525, 2005
16.
Green CR, Flowe-Valencia H, Rosenblum L, et al.: The role of childhood and adulthood abuse among women presenting for chronic pain management. Clinical Journal of Pain 17:359–364, 2001PubMedCrossRef
17.
Feeney GF, Connor JP, Young RM, et al.: Cannabis dependence and mental health perception amongst people diverted by police after arrest for cannabis-related offending behaviour in Australia. Criminal Behaviour and Mental Health 15:249–260, 2005PubMedCrossRef
18.
Couvée JE, Bakker A, Zitman FG: The relevance of psychiatric and somatic comorbidity in depressed chronic benzodiazepine users. Psychotherapy and Psychosomatics 71:263–268, 2002PubMedCrossRef
19.
Langlitz N, Schotte K, Bschor, T: Loperamide abuse in anxiety disorder. Der Nervenarzt 72:562–564, 2001
20.
Haver B: Female alcoholics. I. Psycho-social outcome six years after treatment. Acta Psychiatrica Scandinavica 74:102–111, 1986PubMedCrossRef
21.
Hague WH, Wilson LG: Post-detoxification drug treatment of anxiety and depression in alcohol addicts. Journal of Nervous and Mental Disease 162:354–359, 1976PubMedCrossRef
22.
van Balkom AJ, Beekman AT, de Beurs E, et al.: Comorbidity of the anxiety disorders in a community-based older population in The Netherlands. Acta Psychiatrica Scandinavica 111:401–402, 2005PubMedCrossRef
23.
T Pitkänen: Problem drinking and psychological well-being: A five-year follow-up study from adolescence to young adulthood. Scandinavian Journal of Psychology 40:197–207, 1999PubMedCrossRef
24.
Arnow BA, Hunkeler EM, Blasey CM, et al.: Comorbid depression, chronic pain, and disability in primary care. Psychosomatic Medicine 68:262–268, 2006PubMedCrossRef
25.
Rus-Makovec M, Cebasek-Travnik Z: Co-occurring mental and somatic diagnoses of alcohol dependent patients in relation to long-term aftercare alcohol abstinence and well-being. Psychiatria Danubina 20:194–207, 2008PubMed
26.
Volipicelli JR, Clay KL: Naltrexone in the treatment of alcoholism: Predicting response to naltrexone. Journal of Clinical Psychiatry 56(Suppl 7):39–44, 1995
27.
Sattar SP, Bhatia SC, Petty F: Potential benefits of quetiapine in the treatment of substance dependence disorders. Journal of Psychiatry and Neuroscience 29:452–457, 2004PubMed
Metadaten
Titel
The Association Between Somatic Symptoms, Anxiety Disorders and Substance Use. A Literature Review
verfasst von
Imran Hassan
Rizwan Ali
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 4/2011
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-011-9174-2

Weitere Artikel der Ausgabe 4/2011

Psychiatric Quarterly 4/2011 Zur Ausgabe

Original Paper

Religion and Mental Health During Incarceration: A Systematic Literature Review

Original Paper

Complex Interaction Between Symptoms, Social Factors, and Gender in Social Functioning in a Community-Dwelling Sample of Schizophrenia

Original Paper

Improvement in Global Psychopathology Increases Quality of Life During Treatment of ADHD with Atomoxetine or Stimulants

Original Paper

The Residential Care Alternative for the Acutely Psychotic Patient

Original Paper

Implications of Antisocial Parents

Original Paper

Social Interaction and Drug Attitude Effectiveness in Patients with Schizophrenia

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise